Funder
Society for the Promotion of Research in Experimental Neurology, Vienna, Austria
Publisher
Springer Science and Business Media LLC
Reference237 articles.
1. Ahmadpanah M, Amini S, Mazdeh M, Haghighi M, Soltanian A, Jahangard L, Keshavarzi A, Brand S (2023) Effectiveness of repetitive transcranial magnetic stimulation (rTMS) add-on therapy to a standard treatment in individuals with multiple sclerosis and concomitant symptoms of depression-results from a randomized clinical trial and pilot study. J Clin Med 12:2525
2. Alarcia R, Ara JR, Martín J, Bertol V (2004) [Predicting factors for depression in multiple sclerosis]. Neurologia 19:364–368
3. Alba Palé L, León Caballero J, Samsó Buxareu B, Salgado Serrano P, Pérez Solà V (2017) Systematic review of depression in patients with multiple sclerosis and its relationship to interferonß treatment. Mult Scler Relat Disord 17:138–143
4. Alharbi NA, Alawi SH, Alharbi YM, Alharbi MY, Alsamarh TN, Aldubaiyan AA, Alwasil SA, Alomairi AA (2022) Prevalence of depression and anxiety among adult patients with multiple sclerosis at Riyadh City, Saudi Arabia. Neurosciences (Riyadh) 27:71–78
5. Alhussain H, Aldayel AA, Alenazi A, Alowain F (2020) Multiple sclerosis patients in Saudi Arabia: prevalence of depression and its extent of severity. Cureus 12:e7005